J.ophthalmol.(Ukraine).2018;2:3-6.

https://doi.org/10.31288/oftalmolzh/2018/2/36


Changes in the lamina cribrosa in patient groups differing in severity of diabetic polyneuropathy

M.A. Karliychuk,1 Cand Sc (Med), Assoc. Prof., P.A. Bezditko,2 Dr Sc (Med), Prof.

1 Higher State Educational Establishment of Ukraine «Bukovinian State Medical University»; Chernivtsi (Ukraine)

2 Kharkiv National Medical University; Kharkiv (Ukraine)

E-mail: mari13karli@gmail.com

TO CITE THIS ARTICLE: Karliychuk MA., Bezditko PA. Changes in the lamina cribrosa in patient groups  differing in severity of diabetic polyneuropathy. J.ophthalmol.(Ukraine).2018;2:3-6. https://doi.org/10.31288/oftalmolzh/2018/2/36


Background: To our knowledge, no clinical study has previously been performed to investigate morphometric changes in the lamina cribrosa in diabetes mellitus (DM) patients differing in severity of diabetic polyneuropathy (DPN).

Purpose: To identify changes in the lamina cribrosa in patients with DPN differing in severity of the disease.

Materials and Methods: A total of 575 patients (1150 eyes) with type 2 diabetes mellitus were included in the prospective analysis of changes in the lamina cribrosa. DPN was diagnosed in 210 (36.5%) patients with DM. In addition to routine eye examination, retinal and optic nerve OCT was performed. Thickness of the cribriform plate and scleral canal area were measured.

Results: A relationship was found between the state of the lamina cribrosa and the severity of diabetic polyneuropathy in patients with diabetes mellitus. The mean thicknesses of the lamina cribrosa in DM patients without evidence of DPN, and those with N1A, N1B, N2A, N2B, and N3 stages DPN, were 1.5-fold, 1.9-fold, 2.0-fold, 2.7-fold, 2.8-fold, and 3.0-fold higher than in controls (303 ± 56 μm) (p < 0.001).

Conclusion: We found that, in patients with DM, lamina cribrosa thickness increased with increase in severity of DPN.

Keywords: diabetic polyneuropathy, thickness of the lamina cribrosa, scleral canal area

References

  1. Avetisov SE, Chernenkova NA, Surnina ZV. [Clinical features and diagnosis of diabetic polyneuropathy]. Vestn Oftalmol. 2017;133(5):98-102. Russian
    Crossref   Pubmed
  2. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017 Jan; 40(1):136-54.
    Crossref   Pubmed
  3. Tsyrenzhapova RB. [Peripheral nervous system injury in carbohydrate metabolism impairments]. [Cand Sc (Med) Thesis Abstract]. Tomsk: Siberian State Medical University; 2015. 129 p. Russian
  4. Krasavina MI, Astakhov SY, Shadrichev FE, Dal' NY. [Ophthalmic markers of diabetic polyneuropathy]. Oftal'mologicheskie vedomosti. 2016;IX (1):38–46.  Russian
  5. Shahidi AM, Sampson GP, Pritchard N, Edwards K, Russell A, et al. Exploring retinal and functional markers of diabetic neuropathy. Clin Exp Optom. 2010 Sep; 93(5):309-23.
    Crossref   Pubmed
  6. Srinivasan S, Dehghani C, Pritchard N, Edwards K, Russell AW, et al. Optical coherence tomography predicts 4-year incident diabetic neuropathy. Ophthalmic Physiol Opt. 2017 Jul; 37 (4):451-9.
    Crossref   Pubmed
  7. Terai N, Spoerl E, Haustein M, et al. Diabetes mellitus affects biomechanical properties of the optic nerve head in the rat. Ophthalmic Res.  2012; 47(4):189-94.
    Crossref   Pubmed
  8. Amano S, Kaji Y, Oshika T, et al. Advanced glycation end products in human optic nerve head. Br J Ophthalmol. 2001 Jan;85(1):52-5
    Crossref   Pubmed
  9. Lee EJ, Kim TW, Kim M, Kim H. Influence of lamina cribrosa thickness and depth on the rate of progressive retinal nerve fiber layer thinning. Ophthalmology. 2015; 122:721-9.
    Crossref   Pubmed
  10. Sigal IA, Ethier CR. Biomechanics of the optic nerve head. Exp Eye Res. 2009; 88(4): 799-807.
    Crossref   Pubmed
  11. Spoerl E, Boehm AG, Pillunat LE. The influence of various substances on the biomechanical behavior of lamina cribrosa and peripapillary sclera. Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1286-90.
    Crossref   Pubmed
  12. Boulton AJ. Diabetic neuropathy: classification, measurement and treatment. Curr Opin Endocrinol Diabetes Obes. 2007 Apr; 14 (2):141-5.
    Crossref   Pubmed
  13. Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med.  1998 Jun; 15 (6):508-14.
    Crossref   Pubmed
  14. Bezditko PA, Karliychuk MA, Lukhanin OO, Zavoloka OV. [Peculiarities of spectral coherent tomography using for investigation of the scleral lamina cribrosa thickness and the area of its scleral channel]. Kharkivska khirurgichna shkola. 2017;3-4:63-9. Ukrainian